Abstract
Variants in the ryanodine receptor 2 (RYR2) gene are primarily associated with catecholaminergic polymorphic ventricular tachycardia. However, recent studies have also identified potential links to neurological pathologies, including Alzheimer’s disease, benign epilepsy of childhood, and neurodevelopmental disorders. Despite these findings, there is limited data on the association between RYR2 variants and additional neurological symptoms, such as autonomic dysfunction. This case report describes the clinical progression of a father-son pair, who carry a novel pAsn2517Ser variant in the RYR2 gene, identified through genetic studies. The report highlights distinct neurological manifestations in both individuals: the father exhibited Alzheimer’s-like cognitive dysfunction, while the son presented with an autonomic disorder. This case aims to provide additional information on the role of RyR2 in the brain and the symptomatology associated with pathological variants. Given that both father and son share the same RYR2 mutation, the observed neurological manifestations are likely attributable to this genetic alteration. These cases offer novel clinical insights into the role of cytoplasmic calcium regulators and their impact on the neurological system.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.